Impact of Time from Diagnosis to Treatment on Outcomes of Adults with AML Treated with HMA and Venetoclax: A US-Based, Multi-Center, Real-World, Retrospective Analysis from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Yates, S. J., Weiss, J. J., Sneider, A., Geramita, E., Guru Murthy, G. S., Badar, T., … Shallis, R. M. (2024). Impact of Time from Diagnosis to Treatment on Outcomes of Adults with AML Treated with HMA and Venetoclax: A US-Based, Multi-Center, Real-World, Retrospective Analysis from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood, 144(Supplement 1), 447–447. https://doi.org/10.1182/blood-2024-207116